Clinical Trials Logo
  1. Home
  2. Cerebral Stroke
  3. NCT00119626

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Cerebral Stroke Clinical Trial

Official title:
SAINT I (Stroke - Acute Ischemic - NXY Treatment) A Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter, Phase IIb/III Study to Assess the Efficacy and Safety of Intravenous NXY-059 in Acute Ischemic Stroke.

Clinical Trial Summary

This study will determine if NXY-059 will reduce functional disability from an acute stroke. The study is designed to look at both overall recovery and recovery of motor function, for example muscle strength and coordination.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00119626
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 3
Start date June 2003
Completion date February 2005
View Details
See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05591183 - CERENOVUS Neurothrombectomy Devices Registry
Recruiting NCT03685578 - CERENOVUS Neurothrombectomy Devices Registry
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Completed NCT02827825 - Patients Undergoing Strokes Admitted in Intensive Care Requiring Neurosurgical ICU Crossing: Patient Profile and Prognosis
Recruiting NCT02077582 - Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability N/A
Completed NCT01732679 - Sunnaas International Network´s Stroke Study N/A
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT00311025 - Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications? Phase 1/Phase 2
Withdrawn NCT03804125 - A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
Completed NCT05435404 - Qualitative Study Patient & Physician Experiences Botox COVID-19
Completed NCT03898960 - Post Marketing Study to Evaluate the NIMBUS Device
Not yet recruiting NCT06087094 - A Trial of HRS-7450 in Chinese Healthy Volunteers Phase 1
Completed NCT02207023 - Healthy Lifestyles After Stroke - Stroke Coach N/A
Active, not recruiting NCT02017574 - Motor Learning in Stroke Phase 0
Completed NCT01864382 - "Core Stability" Exercises to Improve Sitting Balance in Stroke Patients N/A
Completed NCT02002390 - Efficacy and Safety of FTY720 for Acute Stroke Phase 2
Recruiting NCT04447599 - Conjunctival and Retinal Vascularization and Small Vessel Disease N/A
Recruiting NCT04157179 - Cerebral Oxygen Metabolism in Children N/A